NCAPH and neoplasm: We evaluated NCAPH levels by IHC in a cohort of patients with luminal A tumours (Table S2A), and again, we confirmed the higher NCAPH protein levels in patients with a poor outcome (presence of liver metastases) than in those who evolved well in the 10‐year follow‐up.